Pediatric Powered Wheelchair Standing Devices: An Exploratory Study

Study Identifier:
22-052-H
ClinicalTrials.gov Identifier:
NCT05117827
EudraCT Identifier:
N/A
EU CT Number:
N/A
Sponsor:
Grand Valley State University
Active, not recruiting

Study Details

Medical Condition
  • All Spinal Muscular Atrophies
Study Drug
    Date
    Nov 2021 - Oct 2026
    Patient Requirements
    Sex: Female & Male
    Age: 5 - 17 Years
    Requirements Information
    Inclusion and Exclusion Criteria
    Inclusion Criteria
    • Is 5-17 years of age. NOTE: Participants must be under 18 for the duration of the study.
    • Diagnosed with a neurodevelopmental condition resulting in an inability to functionally ambulate.
    • Can safely assume and maintain a supported standing position
    • Has sufficient upper extremity and function to safely use a PWSD
    • Can communicate pain or discomfort through verbalization, vocalization, use of augmented communication, etc.
    • Can safely use the PWSD in areas of their home
    • Has at least one parent/caregiver who is able to converse in English and actively participate in a device-use education provided in English
    • The PerMobil PWSD can be set up to meet the child's specific needs
    • Medical Clearance to trial the PWSD
    • Participants must reside in Michigan
    Exclusion Criteria
    • Has a diagnosis of Duchenne muscular dystrophy.
    • Any reason that it would not be safe for the child to use a PWSD

    Protocol Summary

    For children who use a power wheelchair, a powered wheelchair standing device (PWSD) may be considered for daily use. A PWSD allows a child to electronically move between sitting and standing and can be driven in either position. Existing published PWSD research in pediatrics is limited to boys with Duchenne muscular dystrophy (DMD).(1, 2) While these studies provide some insights into PWSD use in boys with DMD, they do not reflect PWSD use in children with other conditions. The purpose of this exploratory study is to determine the feasibility of a research protocol exploring use of a PWSD in children who have neurodevelopmental conditions other than DMD.

    Trial Locations

    Location
    Status
    Location
    Grand Valley State University
    Grand Rapids, Michigan, United States, 49501
    Status
    N/A

    Contact Cure SMA

    User Information

    If you have general questions regarding clinical trials or would like to be added to the Cure SMA mailing list to receive communications regarding future registries, studies, or clinical trials in SMA, please fill out the form below. Fields marked with an asterisk (*) are mandatory.

    • Disability Advocate who does not have SMA
    • I am a healthcare provider
    • I am a researcher
    • I have no direct connection to SMA
    • I have SMA
    • I lost a child to SMA
    • My child has SMA
    • Someone close to me has/had SMA
    • Australia
    • Belgium
    • Brazil
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Estonia
    • France
    • Germany
    • Greece
    • Hong Kong
    • Hungary
    • India
    • Ireland
    • Israel
    • Italy
    • Japan
    • Lebanon
    • Malaysia
    • Mexico
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Puerto Rico
    • Qatar
    • Republic of Korea
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam
    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.